This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionNext revisionBoth sides next revision | ||
home:diseases:cancer [03.13.2019] – [Recent research] sallieq | home:diseases:cancer [03.21.2019] – [Recent research] sallieq | ||
---|---|---|---|
Line 190: | Line 190: | ||
- | ==== Recent research | + | ==== Research |
This result provides a new idea on the anti-tumor mechanism of olmesartan, which may be used as a novel therapeutic target of cervical cancer. | This result provides a new idea on the anti-tumor mechanism of olmesartan, which may be used as a novel therapeutic target of cervical cancer. | ||
Line 203: | Line 203: | ||
Note also that the primary ARBs being evaluated, candesartan and telmisartan, | Note also that the primary ARBs being evaluated, candesartan and telmisartan, | ||
- | ==== H ==== | + | ==== Risk ==== |
< | < | ||
Line 346: | Line 346: | ||
Olmesartan and Bay11-7082 inhibit the MCF-7 cells growth indicating RAS and NF-kappaB pathway blockade lead to cytotoxicity and apoptosis induction against tumour cells. So ARBs and NF-kappaB pathway inhibitors could be considered as anticancer drugs in future. | Olmesartan and Bay11-7082 inhibit the MCF-7 cells growth indicating RAS and NF-kappaB pathway blockade lead to cytotoxicity and apoptosis induction against tumour cells. So ARBs and NF-kappaB pathway inhibitors could be considered as anticancer drugs in future. | ||
+ | In this large population-based gastro-oesophageal cancer cohort, we found moderately reduced cancer-specific mortality among ARB users. However, confirmation in further independent epidemiological studies with sufficient staging information is required. | ||
+ | |||
+ | miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan. | ||
+ | |||
+ | Therapeutic potentials of SCFA receptors [section 7 in | ||
+ | Recent progress in understanding the role of GPR41, GPR43 and GPR109A in health and disease demonstrate that these receptors do not just regulate inflammation and cancer in intestine, but also influence other gastrointestinal functions, allergies, adipogenesis, | ||
- | In this large population-based gastro-oesophageal cancer cohort, we found moderately reduced cancer-specific mortality among ARB users. However, confirmation in further independent epidemiological studies with sufficient staging information is required. | ||
Vitamin D and immune cells stimulate bone marrow disease (({{pubmed> | Vitamin D and immune cells stimulate bone marrow disease (({{pubmed> |